Loading patent…
AssigneeHormos Nutraceutical Oy Ltd.
InventorsMarkku Ahotupa, John Eriksson, Lauri Kangas, Mikko Unkila, Janne Komi, Merja Perälä, Helena Korte
Estimating the term…
The invention relates to a method of inhibiting myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan, where said lignan is enterolactone. The invention is further directed to a method inhibiting myeloperoxidase activity or oxidative burst of macrophages in an individual by administering to the individual an effective amount of a lignan where said lignan is enterolactone or hydroxymatairesinol or a mixture. Finally, the invention is directed to a method of inhibiting oxidative burst or myeloperoxidase activity in neutrophils in an individual by administering to the individual an effective amount of a lignan which is hydroxymatairesinol.
A method of inhibiting myeloperoxidase activity or oxidative burst in macrophages in an individual by administering to said individual an effective amount of a lignan, wherein said lignan is enterolactone or hydroxymatairesinol or a mixture thereof.
Dependencies are inferred from the claim text.